Non Linear Compact Proton Synchrotrons to Improve Human Cancer Cells and Tissues Treatments and Diagnostics through Particle Therapy Accelerators with Monochromatic Microbeams

The most challenging issues facing global society are non–linear compact proton synchrotrons to improve human cancer cells and tissues treatments and diagnostics through particle therapy accelerators with monochromatic microbeams[1-74]. The advancement of nanoscience, nanomedicine and nanotechnology is expected to play an important role for the synchrotron radiation therapy of human cancer cells and tissues[1-74]. Recent efforts have been made in the design of novel anti-cancer Nano drugs for addressing oncology issues. A variety of anti–cancer Nano drugs have been employed in many catalytic processes. However, the clinical, biological, medical, medicinal, pharmaceutical and biochemical applications of anti-cancer Nano drugs in non-linear compact proton synchrotrons to improve human cancer cells and tissues treatments and diagnostics through particle therapy accelerators with monochromatic microbeams is not viable due to the availability and cost of producing them. Therefore, development of simple and economical methodologies for the design of catalytic anti-cancer Nano drugs is much awaited. Nano–architecture is considered to be an efficient route for the design of novel anti-cancer Nano drugs, which provides high efficiency, longer durability and reusability.